In the first Panhellenice Conference of Medical Biochemistry in Athens at 2005, two original projects were presented.
The first one described the anti-platelet activities of thymole, while the second one described the anti-platelet activities of carvacrol.
These two substances decreased the accumulation of platelet by blocking the receptor GPIIb/IIIa (glycoprotein).
These two substances could be used as prevention of the thromboembolic diseases.
Click here for the abstracts in Greek only.
